Day Lewis ‘pausing acquisitions’ as operating profits down 31%

The multiple is “pausing acquisitions” and merging and “disposing” of branches as inflation-linked costs bite, it has revealed.

Day Lewis pharmacy logo
The multiple said it had “outperformed” the market with dispensing growing 6.8%
James Stent

Read more by James Stent

James Stent joined C+D as a digital reporter in May 2023 from the South African human rights news agency GroundUp, where he was senior reporter and consultant editor.

Latest from News

More from Multiples